Copyright
©2014 Baishideng Publishing Group Inc.
World J Hepatol. Jun 27, 2014; 6(6): 394-409
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.394
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.394
Ref. | Study type | Patientswith SLE | NO. of patients with biochemicalalterations and alteration types | Liver histological findings |
Mackay et al[11] | Retrospective | 19 | (n = 19) ↑ AST, ALT | Minimal changes, portal fibrosis, steatosis, inflammation (n = 11) Normal (n = 6) Chronic hepatitis (n = 2) |
Chwalińska-Sadowska et al[12] | Retrospective | 18 | NA | Minimal changes (n = 13) Normal (n =5) |
Runyon et al[13] | Retrospective | 238 | (n = 124) ↑ AST, ALT, total bilirubin, ALP, GGT, LDH (≥ 2 × ULN) | (n = 33) Steatosis (n = 12) Others: cirrhosis, chronic hepatitis, granulomatosis, chronic hepatitis, steatosis, cholestasis, centrilobular necrosis |
Gibson et al[14] | Retrospective | 81 | (n = 64) ↑ AST, ALT, ALP | (n = 7) Portal inflammation (n = 5) Steatosis (n = 1) Chronic hepatitis (n = 1) |
Miller et al[15] | Prospective | 260 | (n = 84) ↑ AST, ALT, ALP | Minimal changes (n = 14) |
Matsumoto et al[17] | Retrospective | 73 | NA | Hepatic arteritis (n = 11) Steatosis (n = 53) RNH (n = 5) Viral hepatitis (n = 2) SLE-PBC overlap syndrome (n = 1) SLE-AIH overlap syndrome (n = 1) |
Luangjaru et al[9] | Retrospective | 225 | (n = 80) ↑ AST, ALT ( ≤ 4 × ULN) | NA |
Chowdhary et al[7] | Retrospective | 192 | (n = 40) ↑ AST, ALT | HCV (n = 3) Steatosis (n =5) SLE-AIH overlap syndrome (n = 4) SLE-PBC overlap syndrome (n = 3) Cryptogenic cirrhosis (n = 1) |
Piga et al[3] | Retrospective | 242 | (n = 59) ↑ AST, ALT (≥ 2 × ULN) | NA |
Her et al[138] | Retrospective | 141 | (n = 46) ↑ Total bilirubin, AST, ALT, LDH, ALP (≥ 2 × ULN) | NA |
Huang et al[90] | Retrospective | 1533 | (n = 134) ↑ AST, ALT (≥ 2 × ULN during 2 yr) | Chronic Hepatitis (n = 6) Minimal changes (n = 4) Normal (n = 3) |
Zheng et al[2] | Retrospective | 504 | (n = 47) ↑ Total bilirubin (13%), ALT (98%), ALP (42%), GGT (49%) | (n = 10) Portal blood cell infiltration (n = 8) Hydropic degeneration (n = 8) Steatosis (n = 2) Mild cholestasis (n = 2) Focal necrosis (n= 1) Nodular cirrhosis (n = 1) |
Takahashi et al[18] | Prospective | 206 | (n = 123) ↑ AST, ALT (99%) ↑ ALP and GGT (81%) | (n = 25) Lupus hepatitis (n = 16): Unspecific reactive hepatitis (88%) Active hepatitis (12%) SLE-AIH overlap syndrome (n = 6): Interface hepatitis (100%) Cirrhosis (33%) SLE-PBC overlap syndrome (n = 3) |
- Citation: Bessone F, Poles N, Roma MG. Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis. World J Hepatol 2014; 6(6): 394-409
- URL: https://www.wjgnet.com/1948-5182/full/v6/i6/394.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i6.394